Company intelligence / Profile preview

Pediadermics

Bethlehem, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Pediadermics is a pediatric skincare company founded by board-certified specialists Dr. Andrew Krakowski and Dr. David Hanson. The company focuses on evidence-based, condition-specific treatments for childhood eczema and atopic dermatitis. Their flagship Easy as 1-2-3 Eczema Management System includes a cleansing primer, a flare control spray formulated with hydrocortisone and Manuka honey, and a petroleum-free barrier repair cream. Pediadermics aims to provide safe, effective, and easy-to-use solutions that bridge the gap between clinical diagnosis and expert home treatment for parents.

Therapeutic areas: Dermatology
Modalities: Small moleculeBotanical extractEmollientCosmetic
Industry: Pharma

Beyond the preview

Go deeper on Pediadermics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pediadermics.

Explore the full profile